Table 1 Primary brain tumor and brain metastasis characteristics of patients presenting with SE (n = 208)
Variable | N (%) |
|---|---|
All patients | 208 (100) |
Adult-type diffuse gliomas | 116 (55.8) |
 Glioblastoma | 85 (40.9) |
 Other | 31 (14.9) |
  Anaplastic astrocytoma | 18 (8.7) |
  Oligoastrocytoma | 7 (3.4) |
  Diffuse astrocytoma | 5 (2.4) |
  Gliomatosis cerebri | 1 (0.5) |
Intracranial extradural tumors | 30 (14.4) |
 Meningioma | 26 (12.5) |
 Other | 4 (2.0) |
  Acoustic neuroma | 1 (0.5) |
  Adamantinous craniopharyngioma | 1 (0.5) |
  Prolaktinoma | 1 (0.5) |
  Pineal tumor | 1 (0.5) |
Metastatic entities (primary tumors) | 53 (25.5) |
 Solid Metastasis | 47 (22.6) |
  Lung cancer (NSCLC & SCLC) | 19 (9.1) |
  Malignant melanoma | 10 (4.8) |
  Breast cancer | 6 (2.9) |
  Colon adenocarcinoma | 5 (2.4) |
  Urothelial carcinoma | 1 (0.5) |
  Pharyngeal carcinoma | 1 (0.5) |
  Epitheloid angiosarcoma | 1 (0.5) |
  Renal cell carcinoma | 1 (0.5) |
  Uterine carcinoma | 1 (0.5) |
  Prostate cancer | 1 (0.5) |
  CUP | 1 (0.5) |
 Leptomeningeal metastatic disease | 6 (2.9) |
  Lung cancer (NSCLC & SCLC) | 2 (1.0) |
  Testicular teratocarcinoma | 1 (0.5) |
  Urothelial carcinoma | 1 (0.5) |
  Cutaneous t-cell lymphoma | 1 (0.5) |
  Esophageal carcinoma | 1 (0.5) |
Other | 9 (4.4) |
  Lymphoma | 7 (3.4) |
  PNET | 1 (0.5) |
  Other | 1 (0.5) |